Previous Page  9 / 14 Next Page
Information
Show Menu
Previous Page 9 / 14 Next Page
Page Background

Page 24

Notes:

conferenceseries

.com

Volume 7, Issue 5 (Suppl)

Otolaryngol

ISSN: 2161-119X Otolaryngol, an open access journal

Otolaryngology 2017

October 18-19, 2017

October 18-19, 2017 Dubai, UAE

4

th

International Conference on

Rhinology and Otology

Topical hyaluronic acid in rhinitis medicamentosa: Could our perspective be changed?

Manuele Casale

Campus Bio-Medico University, Italy

Background&Aim:

is study was designed to prospectively evaluate the role of nebulized hyaluronic acid (HA) as a treatment

for patients with rhinitis medicamentosa (RM). RM is a pathological condition of the nasal mucosa induced by prolonged,

excessive or improper use of topical decongestants.

Methods:

Twenty- ve (25) patients were treated with HA nebulized

via

Spray-sol twice a day (morning and evening) for 10-

days (T1). Subsequently, a er three days of washout, patients were treated with physiological saline nebulized

via

Spray-sol

twice a day (morning and evening) for 10 days (T2).

Results:

e HA Spray-sol treatment group signi cantly improved visual analogue scale (VAS) scores, whereas there

was no statistically signi cant di erence in the saline Spray-sol treatment group, results con rmed by the anterior active

rhinomanometry (AAR) data. An improvement in the Global Rhinitis Score (GRS) was recorded in both groups, but plus in

HA Spray-sol treatment group. Both groups showed a signi cant reduction in mucosal edema and nasal secretions. Patients

treated with HA Spray-sol reduced or even eliminated (11/25 patients) the use of topical decongestant within 10 days of

treatment with HA.

Conclusion:

e results of this study suggest nebulized topical 9-mg sodiumhyaluronate plays a pivotal role in the management

of RM.

Biography

Manuele Casale has worked in Thomas Starzl Transplantation Institute in Pittsburgh, Humber River Hospital and the Hospital for Sick Children in Toronto, University

Hospital in Sofia and House Ear Institute in Los Angeles. He has attended the 20

th

Advanced Course of Surgical Anatomy and Dissection in Otology, the Course

of Surgical Anatomy, Microsurgery Intranasal Endoscopic Anterior Skull Base at the University of Zurich and Masters in Head and Neck Surgery at the National

Cancer Institute Regina Elena in Rome. He carries out research on several topics which include molecular biology, clinical research and innovative design tools

in otolaryngology.

m.casale@unicampus.it

Manuele Casale, Otolaryngol 2017, 7:5 (Suppl)

DOI: 10.4172/2161-119X-C1-022